National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
National Institutes of Health
Description
This grant opportunity funds cancer research projects initiated by investigators. It can support research in areas like cancer biology, prevention, diagnosis, treatment, and control. Applications need to include at least three research projects and an Administrative Core, all focused on a common theme or goal.
This funding opportunity supports investigator-initiated Program Project (P01) applications in cancer research. The program can cover various areas such as cancer biology, prevention, diagnosis, treatment, and control. Applications must include at least three research projects and an Administrat…
Source
Grant ID
PAR-23-059
Agency
National Institutes of Health
Subcategory/Subagency
National Cancer Institute
Program
SBIR
Key Dates
Opportunity Released
December 14, 2022
Open for Submission
December 14, 2022
Submission Deadline
May 7, 2026
Application Window Closes
May 7, 2026
Eligibility
The following categories of applicants are invited to apply:
- Public/State-Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofit Organizations with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofit Organizations without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- For-Profit Organizations (Small Businesses)
- For-Profit Organizations (Other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
Similar opportunities
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Department of Health and Human Services
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Department of Health and Human Services
- Facilitating Clinical Trials in Cancer Prevention and Control
National Institutes of Health
- Exploratory Research Projects for Innovative Molecular Analysis Technologies in Cancer Research
National Institutes of Health
- NIH Research Education Program (R25)
National Institutes of Health